sulfadiazine has been researched along with Hemolysis in 1 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prieto, MJ | 1 |
| Schilrreff, P | 1 |
| Tesoriero, MV | 1 |
| Morilla, MJ | 1 |
| Romero, EL | 1 |
1 other study available for sulfadiazine and Hemolysis
| Article | Year |
|---|---|
Brain and muscle of Wistar rats are the main targets of intravenous dendrimeric sulfadiazine.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Biocompatible Materials; Brain; Cell Survival; | 2008 |